Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer

Conclusion: PSMA RNT and PD-1 blockade synergistically improve therapeutic outcomes in our PC model, supporting the evaluation of RNT and immunotherapy combinations for PC patients.

Source: Journal of Nuclear Medicine - January 19, 2021 Category: Nuclear Medicine Authors: Czernin, J., Current, K., Mona, C. E., Nyiranshuti, L., Hikmat, F., Radu, C. G., Luckerath, K. Tags: Basic Source Type: research